Galectin‐3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2‐positive breast cancer cells

PURPOSE: The aim of this study was to explore the role of galectin‐3 in human epidermal growth factor receptor 2 (HER2)‐positive breast cancer cells and the potential mechanism. METHODS: Kaplan–Meier (KM)‐plot and The Cancer Genome Atlas (TCGA) databases were used to study the role of galectin‐3 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuqiu, Xu, Jiawei, Pan, Wang, Xu, Xiaofan, Ma, Xueping, Chu, Ya'nan, Wang, Lu, Pang, Shuyun, Li, Yujiao, Zou, Bingjie, Zhou, Guohua, Gu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250839/
https://www.ncbi.nlm.nih.gov/pubmed/35599381
http://dx.doi.org/10.1111/1759-7714.14474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250839/
https://www.ncbi.nlm.nih.gov/pubmed/35599381
http://dx.doi.org/10.1111/1759-7714.14474

Ejemplares similares